Pharma-Bio Serv (PBSV) Free Cash Flow (2010 - 2026)
Pharma-Bio Serv's (PBSV) quarterly Free Cash Flow came in at -$367632.0 in Q2 2026, down 20.2% on a YoY basis from -$460696.8 in Q2 2025, and up 6.35% quarter-over-quarter from -$392550.0 in Q1 2026.
Powered by 
Analysis
Pharma-Bio Serv (PBSV) Free Cash Flow (2010 - 2026) Analysis & Trends
Pharma-Bio Serv (PBSV) has reported Free Cash Flow for 17 consecutive years, with -$367632.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Free Cash Flow fell 20.2% year-over-year to -$367632.0; the trailing twelve-month figure through Apr 2026 stood at -$246378.0 (up 83.42% YoY), and the FY2025 full-year result was -$221530.0, up 69.5% from the prior year.
- Free Cash Flow advanced to -$367632.0 in Q2 2026 per PBSV's latest filing, from -$392550.0 in the prior quarter.
- Across five years, Free Cash Flow topped out at $1.1 million in Q3 2022 and bottomed at -$700744.0 in Q2 2024.
- Historically, Free Cash Flow has averaged $41596.7 across 5 years, with a median of -$164730.5 in 2023.
- The sharpest annual moves came in 2024 and 2025: Free Cash Flow plunged 179.32% in 2024, then surged 455.41% in 2025.
- Over 5 years, Free Cash Flow stood at $247954.0 in 2022, then increased by 25.03% to $310016.0 in 2023, then tumbled by 125.35% to -$78590.0 in 2024, then soared by 455.41% to $279316.0 in 2025, then sank by 231.62% to -$367632.0 in 2026.
- According to Business Quant data, Free Cash Flow over the past three periods registered -$367632.0, -$392550.0, and $279316.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Accenture | 124.62 Bn | 115.58 Bn | 6.13 Bn | 3.60 Bn |
| 2 | UL Solutions | 14.92 Bn | 14.51 Bn | 417.00 Mn | 91.00 Mn |
| 3 | Gartner | 11.76 Bn | 10.28 Bn | 1.19 Bn | 378.37 Mn |
| 4 | Tetra Tech | 9.19 Bn | 8.96 Bn | 243.21 Mn | 225.13 Mn |
| 5 | Booz Allen Hamilton Holding | 8.76 Bn | 8.22 Bn | 1.46 Bn | 250.00 Mn |
| 6 | Genpact | 6.27 Bn | 5.75 Bn | 490.34 Mn | 58.52 Mn |
| 7 | Korn Ferry | 4.28 Bn | 3.15 Bn | 685.99 Mn | 271.87 Mn |
| 8 | Fti Consulting | 4.20 Bn | 4.04 Bn | 316.27 Mn | 141.03 Mn |
| 9 | Grand Canyon Education | 4.01 Bn | 3.73 Bn | 204.08 Mn | 97.91 Mn |
| 10 | Pharma-Bio Serv | 12.37 Mn | 3.89 Mn | 902,041.00 | -367,632.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | -367,632.00 |
| Jan 31, 2026 | -392,550.00 |
| Oct 31, 2025 | 279,316.00 |
| Jul 31, 2025 | 234,488.00 |
| Apr 30, 2025 | -305,848.00 |
| Jan 31, 2025 | -429,486.00 |
| Oct 31, 2024 | -78,590.00 |
| Jul 31, 2024 | -672,235.00 |
| Apr 30, 2024 | -700,744.00 |
| Jan 31, 2024 | 725,125.00 |
| Oct 31, 2023 | 310,016.00 |
| Jul 31, 2023 | 956,765.00 |
| Apr 30, 2023 | -250,871.00 |
| Jan 31, 2023 | 867,799.00 |
| Oct 31, 2022 | 247,954.00 |
| Jul 31, 2022 | 1.10 Mn |
| Apr 30, 2022 | -450,646.00 |
| Jan 31, 2022 | -327,886.00 |
| Oct 31, 2021 | 961,231.00 |
| Jul 31, 2021 | 434,614.00 |